Natalie Vinkeles Melchers (Erasmus MC, Department of Public Health) was invited as a guest speaker to a research seminar at the Imperial Collage in London (UK). Natalie presented her work on the projected number of people with onchocerciasis-loiasis co-infection in Africa, from 1995 to 2025. Onchocerciasis, also known as river blindness, is a disease caused by infection with the nematode worm Onchocerca volvulus. Long-term infection may ultimately lead to blindness. Ivermectin is the drug used at a large-scale in onchocerciasis elimination programmes. However, for individuals that are co-infected with Loa loa, the African eye worm, ivermectin may cause severe adverse events (SAEs), potentially even death. The seminar presented estimations on how many people would be at risk of SAEs and how many people would thus benefit from alternative treatment strategies and drugs for onchocerciasis in L. loa endemic areas.
WorldLeish | 16 – 20 May 2017 | Toledo, Spain | 1500 participants | 6th World Congress on Leishmaniasis, organized once every 4 years
Erasmus MC was represented by Epke Le Rutte and Sake de Vlas from the Department of Public Health, who were invited speaker and co-chair respectively of the session “quantitative studies of leishmaniasis transmission and control” in which they highlighted the key policy relevant outcomes of their most recent modeling work on visceral leishmaniasis. In a different session, Epke also presented the work performed at the Department of Public Health at Erasmus MC in collaboration with the faculty of Veterinary Medicine at Utrecht University on the awareness and implementation of control measures by veterinarians against the spread of zoonotic visceral leishmaniasis in Spain and France.
Natalie Vinkeles Melchers, Wilma Stolk and Luc Coffeng from the Erasmus MC (Department of Public Health) were invited to the World Health Organization (WHO), Department of Neglected Tropical Diseases, to discuss their work on a modeling study on the impact of ivermectin on skin and eye disease due to onchocerciasis with projections up to 2025. Drs. Vinkeles Melchers presented her recent work, and showed an expanded disease framework within the individual-based mathematical ONCHOSIM model. She used the disease module to predict trends in the prevalence of onchocercal eye and skin disease during a 25-year time frame since start of MDA. Predicted prevalence was projected for various clinical manifestations due to onchocerciasis; reversible conditions (itch and reactive skin disease) and irreversible manifestations (skin atrophy, depigmentation, hanging groin, vision loss). The meeting was attended by WHO experts in the field of, among others, onchocerciasis, lymphatic filariasis, Chagas, and was deemed very successful.
The Trevi Symposium 2017 will occur on 5th July in Rotterdam. The symposium is in Dutch with the theme “Leven met HIV”. You can find the invitation here.
You can register with Eric van Gorp via firstname.lastname@example.org. Please mention your name, institute and e-mail address.read more